BG-12

Biogen MS Pill’s Early Sales May Help It Beat Estimates
Bloomberg
Mon, 04/29/13 - 10:52 am
MS
multiple sclerosis
Biogen Idec
BG-12
Tecfidera
Biogen Wins FDA Approval of MS Pill
TheStreet.com
Thu, 03/28/13 - 08:45 am
Biogen Idec
FDA
MS
BG-12
multiple sclerosis
Tecfidera
Biogen And The Progress In Multiple Sclerosis Treatment
Seeking Alpha
Tue, 03/26/13 - 10:26 am
MS
multiple sclerosis
Biogen Idec
Tecfidera
BG-12
Biogen, Baxter, Sanofi, Gilead Win EU Endorsements
Investors.com
Fri, 03/22/13 - 11:45 am
Biogen Idec
Baxter International
Sanofi
Gilead
Europe
BG-12
Tecfidera
Aubagio
HyQvia
Halozyme
Stribild
4 Key Drug Approvals Expected In The Next 30 Days
investors.com
Sat, 03/16/13 - 10:55 am
Biogen Idec
BG-12
multiple sclerosis
MS
Remodulin
United Therapeutics
lung disease
Invokana
JNJ
diabetes
type 2 diabetes
Levadex
Allergan
migraine
A Strong Growth Opportunity In Multiple Sclerosis
Motley Fool
Wed, 02/20/13 - 11:46 am
multiple sclerosis
MS
Elan
Biogen Idec
Tysabri
Teva
XenoPort
Sanofi
BG-12
Is Teva Just Looking Out for Itself
Motley Fool
Sat, 01/12/13 - 11:14 am
Teva
Copaxone
multiple sclerosis
MS
generics
Biogen
BG-12
Teva Petitions FDA To Delay Biogen MS Drug
Pharmalot
Thu, 01/10/13 - 09:53 am
FDA
Teva
Biogen Idec
MS
multiple sclerosis
Copaxone
BG-12
2013 Should Be Interesting for Multiple Sclerosis Drugs
Motley Fool
Thu, 01/3/13 - 11:39 am
MS
multiple sclerosis
Teva
Copaxone
Rebif
Pfizer
Merck KGaA
Biogen Idec
Avonex
Bayer
Betaseron
Novartis
Extavia
Sanofi
Tysabri
Aubagio
Elan
Gilenya
BG-12
Keep an Eye on These Five New Drugs in the First Quarter of 2013
Minyanville
Thu, 12/27/12 - 10:16 pm
Rytary
GSK
Impax Labs
Celgene
pomalidomide
Roche
T-DM1
Immunogen
Eliquis
Pfizer
Bristol-Myers Squibb
Biogen Idec
BG-12
5 Drug Hopefuls That Are Going to Change Your Life: Part 1
Motley Fool
Thu, 11/15/12 - 04:25 pm
BG-12
Biogen Idec
MS
multiple sclerosis
Biogen Idec's BG-12 PDUFA Delay is a Buying Opportunity
Yahoo/Reuters
Wed, 10/31/12 - 11:38 am
Biogen Idec
BG-12
Biogen slips as FDA extends review of MS drug
Yahoo/AP
Sat, 10/20/12 - 10:29 am
Biogen
BG-12
MS
multiple sclerosis
Biogen Says Its FDA Delay Unrelated To Abbott's Failed Medicine
Forbes
Fri, 10/19/12 - 11:02 am
FDA
MS
Biogen Idec
Abbott Labs
BG-12
Bardoxolone
Review of Biogen Idec's MS Drug Delayed
Minyanville
Thu, 10/18/12 - 11:44 am
MS
multiple sclerosis
Biogen Idec
FDA
BG-12
Blockbuster buzz: 15 top therapies in late-stage development
Fierce Biotech
Thu, 10/11/12 - 10:49 am
vortioxetine
Vectura
tofacitinib
Takeda
T-DM1
Sanofi
Roche
REGN727
Regeneron
Reata
QVA149
Pfizer
Odanacatib
Novartis
MorphoSys
Merck
macitentan
Lundbeck
Immunogen
GSK
GS-7977
Gilead
gantenerumab
Eliquis
darapladib
Bristol-Myers Squibb
Biogen Idec
BG-12
Bayer
Bardoxolone
Anacetrapib
Alpharadin
Algeta
Actelion
AbbVie
Battle Lines Drawn in the MS Market
Motley Fool
Wed, 09/26/12 - 10:56 am
multiple sclerosis
MS
BiogenIdec
BG-12
Sanofi
Aubagio
Gilenya
Novartis
Multiple sclerosis drugs seen gaining traction
Marketwatch
Fri, 09/21/12 - 11:32 am
MS
multiple sclerosis
BiogenIdec
BG-12
Aubagio
Sanofi
Standard Review for Biogen's BG-12
Yahoo/Zacks
Sat, 05/12/12 - 11:51 am
Biogen Idec
BG-12
multiple sclerosis
Biogen Says Data Highlight Safety Profile For BG-12 MS Drug
FOX Business
Tue, 04/24/12 - 10:27 am
Biogen Idec
BG-12
multiple sclerosis
MS

Pages